Daclizumab Subcutaneous and MagDelay
Determining the interaction of Daclizumab Subcutaneous and MagDelay and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: calcium carbonate / magnesium chloride
Brand name: Mag64, MagDelay, Nu-Mag, Slow-Mag, Magnesium Chloride With Calcium, Slow Magnesium Chloride with Calcium
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-MagGel
- Daclizumab Subcutaneous-Maginex
- Daclizumab Subcutaneous-Maginex DS
- Daclizumab Subcutaneous-Magnacet
- Daclizumab Subcutaneous-MagneBind 400
- Daclizumab Subcutaneous-MagneBind 400 RX
- MagDelay-Dacogen
- MagDelay-Dacomitinib
- MagDelay-Dactinomycin
- MagDelay-Dactinomycin Injection
- MagDelay-Dactinomycin Intravenous
- MagDelay-Daklinza